Evaluation of a Mapleson D CPAP system for weaning of mechanical ventilation in pediatric patients

BACKGROUND: Over the last years, we have used a flow-inflating bag circuit with a nasotracheal or nasopharyngeal tube as an interface to deliver effective CPAP support in infants (“Mapleson D CPAP system”). The primary goal of this study was to assess the usefulness of the “Mapleson D CPAP system” for weaning of mechanical ventilation (MV) in infants who received MV over 24 h. MATERIALS AND METHODS: All infants who received MV for more than 24 h in the last year were enrolled in the study. Demographic data included age, gender, weight, and admission diagnosis. Heart rate, respiratory rate, blood pressure, and oxygen saturation were measured during MV, 2 h after the nasotracheal Mapleson D CPAP system and 2 h after extubation. Patients were classified into two groups: patients MV more than 48 h, and patients with MV fewer than 48 h. P < 0.05 was considered statistically significant. RESULTS: A total of 50 children were enrolled in the study, with a median age was 34 ± 45 months (range, 1–59 months) and median weight was 11.98 ± 9.31 kg (range, 1–48 kg). Median duration of MV was 480 h (range, 2–570). There were no significant differences in PaO(2), PaCO(2), and pH among MV, 2 h after the nasotracheal Mapleson D CPAP system and 2 h after extubation and spontaneous ventilation with the nasopharyngeal Mapleson D CPAP system or with nasal prongs. The overall extubation failure rate was 26% (n = 13). Weight and age were significantly associated with extubation failure (P < 0.05). CONCLUSIONS: The Mapleson D CPAP system, in our opinion, is a useful and safe alternative to more complex and expensive noninvasive CPAP and BiPAP weaning from MV in infants.